Shownotes
Episode 162 — 07 November 2026
This week, we cover the FDA's draft guidance on real-world evidence, the FTC's settlement with CVS Caremark, ICER's expansion of early-phase scientific advice, and NICE's updated guidance on real-world evidence for technology appraisals.
Hosted by Marcus and Sara.
Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape.
Full transcript and sources at outcomes-analytica.no/podcast

